Ameritas Investment Partners Inc. Buys 1,316 Shares of Synopsys, Inc. $SNPS

Ameritas Investment Partners Inc. boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 19.8% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 7,963 shares of the semiconductor company’s stock after purchasing an additional 1,316 shares during the period. Ameritas Investment Partners Inc.’s holdings in Synopsys were worth $3,929,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in SNPS. Alpine Bank Wealth Management lifted its holdings in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. raised its holdings in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Synopsys in the third quarter worth about $27,000. SOA Wealth Advisors LLC. bought a new position in shares of Synopsys during the third quarter valued at approximately $28,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Synopsys in the 3rd quarter worth about $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
• Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
• Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
• Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
• Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
• Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades

Insider Activity at Synopsys

In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 4,157 shares of company stock valued at $1,945,036. 0.62% of the stock is owned by company insiders.

Synopsys Stock Down 0.6%

Synopsys stock opened at $439.94 on Monday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The business’s 50-day moving average price is $474.06 and its 200 day moving average price is $481.90. The firm has a market cap of $84.27 billion, a price-to-earnings ratio of 55.06, a price-to-earnings-growth ratio of 3.66 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the firm earned $3.40 EPS. The firm’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have commented on SNPS shares. Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. HSBC lowered Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research report on Friday. JPMorgan Chase & Co. upped their price objective on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Morgan Stanley boosted their price objective on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Finally, Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Synopsys has an average rating of “Hold” and a consensus target price of $547.00.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.